Owing to the suggestion that increased expression of Survivin in human gliomas is positively correlated with an ascending pathological grade of tumour (Sasaki et al, 2002), we further evaluated the expression pattern of Survivin between 15 pairs of secondary GBMs and their pre-existing lower grade lesions. Here, BIRC5 is linked to central nervous system cancer.